首页> 外文会议>IEEE International Conference on Plasma Science >Inducing intracellular ros and cellular redox without cell death in mesenchymal cells using microsecondpulsed DBD plasma
【24h】

Inducing intracellular ros and cellular redox without cell death in mesenchymal cells using microsecondpulsed DBD plasma

机译:使用微小脉动DBD血浆诱导细胞内ROS和细胞氧化还原,在间充质细胞中没有细胞死亡

获取原文

摘要

Intracellular reactive oxygen species (ROS) is a known activator of cell signaling, however too much ROS causes cell death. Our goal was to determine the optimal microsecond-pulsed Dielectric Barrier Discharge plasma (DBD-plasma) treatment dose (J/cm2) in which ROS/redox responses would potentially activate cell function but not cell death. In this study, we applied DBD-plasma to mesenchymal cells and evaluated intracellular ROS generation, redox, mitochondrial membrane potential and the Live/Dead response to increasing levels of DBD-plasma. Using fluorescent indicators to measure superoxide anion (O2−.) (MitoSOX™ Red), reduced glutathione (GSH) (ThiolTracker™ Violet) and mitochondrial membrane potential (ΔΨm) (MitoTracker® Red), we show that DBD-plasma doses of 1–5 J/cm2 stimulated an immediate (minutes) increase in O2− levels with a concomitant decrease in reduced thiol. The mitosox fluorescence intensity increased with DBD-plasma treatments until 1 J/cm2, after which levels plateaued regardless of increased dose. Reduced thiol fluorescent intensity showed an immediate 50% decrease regardless of DBD-plasma treatment dose. A 20% decrease in mitochondrial membrane potential occurred at 2 hrs post-DBD-plasma treatments 1 – 5 J/cm2, with significant cell death observed (fluorescent Live/Dead assay; syto- 13/propidium iodide) at levels of 2.5 J/cm2 and greater. Taken together, these results provide a range in which DBD (0–2.0 J/cm2) intracellular ROS generation and cellular redox change with little effect on cell viability. Understanding the optimal treatment levels DBD-plasma interactions is essential for developing DBD-plasma treatments to induce directed cell function such as; proliferation, differentiation and targeted gene expression.
机译:细胞内反应性氧(ROS)是一种已知的细胞信号传导活化剂,但是过多的ROS导致细胞死亡。我们的目标是确定最佳的微秒脉冲介质阻挡放电等离子体(DBD - 血浆)处理剂量(J / cm2),其中ROS /氧化还原反应可能激活细胞功能但不是细胞死亡。在该研究中,我们将DBD - 血浆施加到间充质细胞,并评估细胞内ROS生成,氧化还原,线粒体膜电位和对DBD血浆水平水平的实时/死亡反应。使用荧光的指标来衡量超氧阴离子(O 2 - )(MitoSOX™红色),还原型谷胱甘肽(GSH)(ThiolTracker™紫)和线粒体膜电位(线粒体膜电位)(MitoTracker®红),我们表明DBD - 等离子体剂量为1-5J / cm 2 刺激的立即(分钟)含量增加(分钟),随着硫醇的还原而伴随地减少。 MitoSox荧光强度随DBD - 血浆处理而增加,直至1 J / cm 2 ,之后,无论增加剂量如何,均有稳定的水平。无论DBD - 血浆治疗剂量如何,降低硫醇荧光强度显示出直接50%降低。线粒体膜电位的降低20%在DBD - 血浆治疗后的2小时内发生1-5J / cm 2 ,观察到显着的细胞死亡(荧光实时/死导; SYTO-13 / Propidium)碘化物)含量为2.5J / cm 2 和更大。总之,这些结果提供了一种范围,其中DBD(0-2.0J / cm 2 )细胞内ROS产生和细胞氧化还原变化几乎没有对细胞活力的影响。理解最佳治疗水平DBD-血浆相互作用对于开发DBD-血浆处理是必不可少的,以诱导指向细胞功能;增殖,分化和靶向基因表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号